Dexamethasone as an Adjuvant to Bupivacaine in Suprazygomatic Maxillary Nerve Block
Status:
Not yet recruiting
Trial end date:
2025-03-01
Target enrollment:
Participant gender:
Summary
Postoperative pain score, Faces, Legs, Activity, Cry, Consolability (FLACC) is the primary
outcome. The secondary outcomes are the first-time requested analgesia, the number of
children required analgesia, the total amount of analgesic requirements during first the 24
hours.